Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • đŸ”„
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Extraordinary pictures show what a common antibiotic does to E. coli
Tech and Science

Extraordinary pictures show what a common antibiotic does to E. coli

Last updated: September 29, 2025 2:09 pm
Share
Extraordinary pictures show what a common antibiotic does to E. coli
SHARE

An E. coli bacterium before and after treatment with polymyxin B

The top image depicts untreated E. coli; the bottom image shows the same bacterium after 90 minutes of exposure to the antibiotic polymyxin B.

Carolina Borrelli, Edward Douglas et al./Nature Microbiology

The mechanism by which polymyxins, a class of antibiotics, breach the defenses of bacteria has been revealed through high-resolution microscopy, offering new insights for developing treatments against drug-resistant infections.

Polymyxins are typically reserved as last-line treatments for certain gram-negative bacteria responsible for serious infections such as pneumonia, meningitis, and typhoid fever. As noted by Andrew Edwards from Imperial College London, “The top three World Health Organization priority pathogens are all gram-negative bacteria, reflecting their complex cell envelope.”

These bacteria possess an outer membrane made of lipopolysaccharides, which functions as a barrier. While it’s known that polymyxins target this layer, the specific mechanisms by which they disrupt it and kill the bacteria were previously unclear. Additionally, it was uncertain why these drugs sometimes failed.

In research conducted by Edwards and his team, they employed biochemical assays and atomic force microscopy to discover that polymyxin B, one of the two polymyxins approved for clinical use, triggers the formation of bulges on the surface of gram-negative bacteria like E. coli.

Shortly after the appearance of these protrusions, the bacteria began shedding lipopolysaccharides, evident in the surrounding solution.

The team concluded that the presence of the antibiotic prompts the bacteria to accelerate the incorporation of lipopolysaccharide “bricks” into their protective exterior. However, this rapid construction coincides with the loss of some bricks, creating temporary vulnerabilities for the antibiotic to penetrate and kill the cells.

See also  Landmark Langlands Proof Advances Grand Unified Theory of Math

“The antibiotics act like a crowbar that facilitates the removal of these bricks from the wall,” Edwards noted. “The outer membrane doesn’t collapse entirely; it doesn’t fall off. However, there are observable gaps that allow the antibiotic to access the inner membrane.”

The researchers also identified a critical reason for the antibiotic’s variable efficacy: it predominantly affects bacteria that are actively growing. In contrast, when bacteria enter a dormant state—often as a survival tactic against environmental challenges like nutrient shortages—polymyxin B loses its effectiveness because the bacteria halt armour production.

Progressive exposure of E. coli to polymyxin B demonstrating membrane changes over time

Images showing the changes to the outer layer of E. coli exposed to polymyxin B over time, from untreated to 90 minutes post-exposure.

Carolina Borrelli, Edward Douglas et al. / Nature Microbiology

Interestingly, the researchers found that supplying sugars to dormant E. coli cells could spur them back into activity, resuming lipopolysaccharide construction, and leaving them vulnerable to polymyxin B within just 15 minutes. This phenomenon may also apply to polymyxin E, the other polymyxin in clinical use.

Edwards suggests that while targeting dormant bacteria with sugars to reawaken them could be a strategy, it comes with risks, as it may lead to rapid bacterial proliferation at infection sites. Instead, he proposes exploring combination therapies that could bypass the dormant state without triggering increased bacterial growth.

Topics:

TAGGED:AntibioticcoliCommonextraordinaryPicturesShow
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Mid-Century Modern’ Canceled After One Season at Hulu ‘Mid-Century Modern’ Canceled After One Season at Hulu
Next Article Fetterman rejects ‘Nazi,’ ‘fascist’ labels for opponents while affirming loyalty to the Democrats Fetterman rejects ‘Nazi,’ ‘fascist’ labels for opponents while affirming loyalty to the Democrats
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

President Trump is Stepping Up Where Democrats Won’t – The White House

In a scene reminiscent of a chaotic street theater, radical left activists have taken to…

June 9, 2025

‘The Basketball 100’ GOAT Points: A new way to look at the greatest (players) of all time

"The Basketball 100" is a comprehensive ranking of the top 100 NBA players of all…

November 27, 2024

Acrobatic Poses Invigorate Urban Buildings in Monumental Murals by Artez — Colossal

Artez, a talented mural artist, is captivating audiences with his stunning large-scale murals that blend…

August 4, 2025

NYC woman murdered 33 years ago finally ID’d with advanced DNA testing: DA

In a tragic turn of events, a woman who was brutally murdered in Queens over…

December 30, 2024

TikTokers Claim ‘Vabbing’ Will Help Dating. Here Are The Issues

Dating in today's world can be a bit complex, with everyone looking for unique ways…

March 29, 2025

You Might Also Like

Bugonia’s Ending Explained: The Wildest Conclusion of Any Film in 2025
Tech and Science

Bugonia’s Ending Explained: The Wildest Conclusion of Any Film in 2025

October 30, 2025
How Are Annual Flu Vaccines Made?
Tech and Science

How Are Annual Flu Vaccines Made?

October 30, 2025
Navan IPO tumbles 20% after historic debut under SEC shutdown workaround
Tech and Science

Navan IPO tumbles 20% after historic debut under SEC shutdown workaround

October 30, 2025
The US is unlikely to test nuclear weapons, despite what Trump says
Tech and Science

The US is unlikely to test nuclear weapons, despite what Trump says

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?